SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-011332
Filing Date
2024-04-22
Accepted
2024-04-22 18:36:44
Documents
1
Period of Report
2024-04-18

Document Format Files

Seq Description Document Type Size
1 form4-04222024_100438.html 4  
1 form4-04222024_100438.xml 4 5032
  Complete submission text file 0001415889-24-011332.txt   6601
Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Issuer) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 395 OYSTER POINT BLVD. SUITE 217 SOUTH SAN FRANCISCO CA 94080
Business Address
Blackman Samuel C. (Reporting) CIK: 0001863676 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40431 | Film No.: 24862332